Detalhe da pesquisa
1.
Prolonged viral suppression with anti-HIV-1 antibody therapy.
Nature
; 606(7913): 368-374, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35418681
2.
Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
J Virol
; 87(1): 187-98, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23055568
3.
Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons.
AIDS
; 37(8): 1203-1207, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37070542
4.
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana.
Sci Transl Med
; 15(703): eadh0004, 2023 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37406137
5.
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.
Nat Med
; 28(11): 2424-2435, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36253609
6.
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody.
Nat Commun
; 13(1): 1219, 2022 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35264559
7.
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.
Clin Infect Dis
; 52(7): 925-8, 2011 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21427401
8.
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance.
J Virol
; 84(21): 11235-44, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20719956
9.
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
J Infect Dis
; 201(6): 803-13, 2010 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20151839
10.
Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens.
Open Forum Infect Dis
; 8(10): ofab474, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34692891
11.
Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.
J Exp Med
; 198(10): 1551-62, 2003 Nov 17.
Artigo
Inglês
| MEDLINE | ID: mdl-14623909
12.
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.
J Infect Dis
; 200(11): 1724-8, 2009 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19874179
13.
Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.
Antimicrob Agents Chemother
; 53(11): 4686-93, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19687240
14.
Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein.
J Virol
; 82(11): 5584-93, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-18353956
15.
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.
Sci Rep
; 8(1): 3199, 2018 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-29453451
16.
Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.
Gastroenterology
; 140(3): 755-60, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21255574
17.
High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.
AIDS Res Hum Retroviruses
; 33(3): 234-245, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27604829
18.
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review.
Hepatol Commun
; 1(5): 379-390, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29404466
19.
Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.
Retrovirology
; 3: 90, 2006 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-17144914
20.
Cellular entry of HIV: Evaluation of therapeutic targets.
Curr Pharm Des
; 12(16): 1963-73, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-16787241